Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I indomethacin plus platinum-based chemotherapy study
NL-OMON45105Phase 1Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of indomethacin in cancer (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Safety of the combination of platinum-based therapy and indomethacin. Started Oct 2012; status: active, not recruiting.
02
Drugs
indomethacin
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON45105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45105.